2.1. HPLC Analysis of Ginsenoside Standards
Figure 1 shows chemical structures of 9 ginsenosides analyzed in this study. Initially a gradient mobile phase of deionized water (A) and acetonitrile (B) used by Cramer and Nold [
24] was employed to separate 10 ginsenoside standards including internal standard saikosaponin A. However, the separation efficiency remains inadequate. Thus, by modifying the gradient mobile phase of deionized water (A) and acetonitrile (B) as the following: 75% A and 25% B in the beginning, maintained for 1.5 min, changed to 30% A in 18 min, 0% A in 20 min, a total of 10 ginsenoside standards including Rg1, Re, Rf, Rb1, Rc, Rb2, Rd, Rg3, CK and saikosaponin A were adequately separated within 18 min (
Figure 2A). In several previous studies, Chen et al. [
25] developed a gradient mobile phase of 0.1% formic acid in water (A) and acetonitrile containing 0.1% formic acid (B) to separate 7 ginsenosides within 30 min by UHPLC-QTOF-MS. Similarly, Uhr et al. [
26] developed a gradient mobile phase of 0.02% acetic acid solution (A) and acetonitrile containing 0.02% acetic acid (B) to separate 8 ginsenosides within 70 min by HPLC-MS/MS. In a recent study, Xu et al. [
27] developed a gradient mobile phase of acetonitrile (A) and water (B) to separate 19 ginsenosides within 32 min by HPLC. By comparison, the retention time for separation of 10 ginsenosides was much shorter by using the gradient mobile phase in our study and an adequate separation efficiency was attained.
Figure 2B shows HPLC chromatogram of ginsenoside in a ginseng root residue sample, and a total of 9 ginsenosides including Re, Rg1, Rf, Rb1, Rc, Rb2, Rd, Rg3 and CK were present with the retention time ranging from 3.79–17.43 min.
2.2. Identification and Quantitation of Ginsenosides in Ginseng Root Residue by HPLC-DAD-ESI-MS
Table 1 shows the
m/
z value of ginsenoside standards and ginsenosides in ginseng root residue extract by HPLC-MS. A total of 9 ginsenosides including Re, Rg1, Rf, Rb1, Rc, Rb2, Rd, Rg3 and CK were identified in ginseng root residue extract through comparison of
m/
z and retention time of ginsenosides in ginseng root residue extract with that of ginsenoside standards (
Table 1 and
Figure 2). For quantitation, the linear regression equations of Re, Rg1, Rf, Rb1, Rc, Rb2, Rd, Rg3 and CK were prepared with y = 0.6022x + 0.0592, y = 0.7347x + 0.0642, y = 0.7456x + 0.0819, y = 0.5131x + 0.0506, y = 0.5194x + 0.0497, y = 0.4880x + 0.0502, y = 0.6788x + 0.1038, y = 0.8957x + 0.0828 and y = 0.8093x + 0.0184, respectively, and R
2 all higher than 0.99. Rb1 was found to be present in the highest amount (23,254.89 μg/g), followed by Re (9081.64 μg/g), Rd (1300.39 μg/g), Rc (949.37 μg/g), Rb2 (558.26 μg/g) and Rg1 (305.76 μg/g), while Rf, Rg3 and CK remained undetected (
Table 2).
The method validation revealed that the LOD for Re, Rg1, Rf, Rb1, Rc, Rb2, Rd, Rg3 and CK was 0.07, 0.08, 0.20, 0.12, 0.23, 0.21, 0.52, 0.63, and 0.56 μg/g, respectively, while the LOQ was 0.20, 0.23, 0.60, 0.38, 0.69, 0.65, 1.59, 1.90 and 1.69 μg/g.
Table 3 shows the recovery data of ginsenosides by HPLC-DAD-ESI-MS, with the mean recovery being from 101.64% (Rf)-114.32% (Rg3). The repeatability and intermediate precision data are shown in
Table 4, with the RSD being from 0.31–2.67% for the former and 1.67–9.18% for the latter. This outcome implied that a high accuracy and precision was attained for the HPLC-DAD-ESI-MS method employed in this study with an insignificant matrix effect for determination of ginsenosides in American ginseng root residue.
2.7. Identification and Quantitation of Ginsenosides in Ginseng Root Residue by UPLC-HRMS-MS/MS
Table 6 shows retention time,
m/
z of precursor ion and product ion as well as collision energy (V) and RF lens (V) of 9 ginsenosides by tandem mass spectrometry (UPLC-HRMS-MS/MS), with retention time ranging from 2.45 min (Rg1) to 5.76 min (CK). The product ions with higher signal intensity were used for quantitation including 638.44 for Rg1 and Re, 475.38 for Rf, 220.98 for Rb1, 945.49 for Rc, 783.39 for Rb2, 783.5 for Rd, 621.43 for Rg3 and 161.05 for CK, while those with lower signal intensity were used for identification including 476.42 for Rg1, 476.54 for Re, 637.44 for Rf, 945.48 for Rb1, 765.47 for Rc, 765.48 for Rb2, 621.44 for Rd, 459.37 for Rg3 and 161.05 for CK. Similar
m/
z data used for identification of ginsenosides in ginseng was reported by Uhr et al. [
26] and Zhang et al. [
32]. Furthermore, the linear regression equations for Re, Rg1, Rf, Rb1, Rc, Rb2, Rd, Rg3 and CK were Y = (2.4670 × 10
−2) X + (2.3159 × 10
−2), Y = (8.8520 × 10
−3) X + (3.7330 × 10
−4), Y = (10.4032 × 10
−2) X + (7.8584 × 10
−6), Y = (4.5967 × 10
−3) X + (7.5923 × 10
−2), Y = (9.9804 × 10
−3) X + (1.5325 × 10
−3), Y = (6.2406 × 10
−3) X + (2.3401 × 10
−4), Y = (2.1853 × 10
−2) X + (1.0420 × 10
−2), Y = (3.3966 × 10
−2) X + (5.8098 × 10
−4) and Y = (7.2961 × 10
−3) X + (2.3964 × 10
−5), respectively, and R
2 being all higher than 0.99.
The method validation revealed that the LOD of Re, Rg1, Rf, Rb1, Rc, Rb2, Rd, Rg3 and CK was 0.089, 2.133, 0.705, 1.373, 1.553, 2.191, 1.039, 0.912 and 0.089 ng/g, respectively, while the LOQ was 0.269, 6.463, 2.135, 4.161, 4.707, 6.640, 3.147, 2.763 and 0.269 ng/g, respectively. The recovery data of ginsenosides by UPLC-HRMS-MS/MS is shown in
Table 7 and the mean recovery ranged from 86.82% (Rf) to 100.83% (Rc), implying an insignificant matrix effect for determination of ginsenosides in American ginseng root residue.
Table 8 shows the repeatability and intermediate precision data of ginsenosides with the RSD being from 1.44–7.08% for the former and 3.76–8.31% for the latter. Taken together, all the recovery and precision data of HPLC-DAD-ESI-MS and UPLC-HRMS-MS/MS met the method validation guideline issued by Taiwan Food and Drug Administration (TFDA) [
33], implying that the method developed in our study for determination of ginsenosides in ginseng root residue possessed high accuracy and precision.
Following quantitation by UPLC-HRMS-MS/MS, Rb1 was present in the largest amount (21,256.18 μg/g), followed by Re (7958.80 μg/g), Rd (1935.39 μg/g), Rc (1262.94 μg/g), Rg1 (934.56 μg/g), Rb2 (583.68 μg/g), Rg3 (353.16 μg/g), Rf (4.71 μg/g) and CK (<LOD) (
Table 2).
It has been well documented that ginsenoside contents can be varied depending on part and variety of ginseng. For instance, Kang and Kim [
28] compared ginsenoside contents in different parts of Korean ginseng and reported that the total ginsenoside content was present in the highest amount in ginseng leaf (3538.71 mg/100 g), followed by ginseng root hair (1186 mg/100 g) and ginseng root (292.87 mg/100 g). More specifically, Rh1, Rb3 and Rd were present at a high level in ginseng leaf, while both Rc and Re were present at a high level in ginseng root hair and Rc, Rb1, Rg1 and Rh1 at a high level in ginseng root [
28]. Similarly, Li et al. [
34] compared ginsenoside contents in
Panax ginseng and
Panax quinquefolius leaves, with Re showing the highest level (7.394–8.286 mg/g), followed by F1 (4.409–4.770 mg/g), Rd (3.390–3.737 mg/g), Rb2 (2.635–2.792 mg/g), Rg1 (2.405–3.996 mg/g) and Rc (1.098–1.211 mg/g) for the former, while for the latter, Re was present at the highest level (8.162 mg/g), followed by Rb3 (4.977 mg/g), Rb2 (3.543 mg/g), Rd (3.424 mg/g), F1 (3.271 mg/g) and Rg1 (1.644 mg/g). Comparatively, in our study both Rb1 and Re dominated in ginseng root residue prepared from ginseng root with a much higher level than that reported in the literature.
Compared to HPLC-DAD-ESI-MS, the total ginsenoside content in ginseng root residue as determined by UPLC-HRMS-MS/MS was similar (
Table 2). However, three ginsenosides including Rf, Rg3 and CK remained undetected in ginseng root residue by HPLC-DAD-ESI-MS, while only CK was undetected by UPLC-HRMS-MS/MS. Moreover, it is evident that the contents of Re and Rb1 were higher in American ginseng root residue by HPLC-DAD-ESI-MS, while Rg1, Rc, Rb2 and Rd were higher by UPLC-HRMS-MS/MS, which may be attributed to the difference in the analytical technique (HPLC versus UPLC), separation conditions and detector signal response (single quadrupole ESI-MS versus HRMS-MS/MS) for each ginsenoside. This outcome implied that UPLC-HRMS-MS/MS possessed a much higher sensitivity than HPLC-DAD-ESI-MS, as evident by a much lower LOD and LOQ of 9 ginsenosides when detected by the former.
Obviously, the orbitrap HRMS tandem spectrometry detection provides high resolution and mass accuracy with improved scan rates to attain 60,000–100,000 resolution at 1 Hz for generating adequate signal intensity even for an UPLC peak width of 5–20 s [
35]. Compared to triple-quadrupole mass detection, HRMS can provide higher sensitivity by eliminating background noise as well as facilitating higher selectivity and specificity by differentiating compounds with small mass difference. Furthermore, unlike triple-quadrupole, HRMS mass detection by orbitrap or QTOF enables both qualitative and quantitative analyses of samples with multiple targets and compounds involving complex fragmentation patterns [
35]. HRMS also allows faster method development with minimal compound optimization.
Among the 9 ginsenosides determined in this study, the ginsenoside Rb1 was shown to be present in the largest amount in American ginseng root residue. Generally, Rb1 is abundant in roots, rhizomes and root hairs of ginseng when compared with stem and leaves. Numerous reports have shown that Rb1 is responsible for most of the ginseng plant’s pharmacological activity especially in the cardiovascular, endocrine and immune systems [
36]. Most importantly, Rb1 is the key component for neuroprotection with a recent finding suggesting a greater neuroprotective activity for Rb1 when administered intranasally [
37]. A recent review on analysis of preclinical evidence of Rb1 highlighted that its neuroprotective effect was mainly through attenuating brain water content, promoting the bioactivity of neurogenesis, antioxidative, anti-inflammatory and anti-apoptosis effects with enhanced cerebral circulation and energy supplementation [
38]. In a study dealing with anti-amnestic and anti-aging effects, Cheng et al. [
39] demonstrated the potential of Rb1 and Rg1 to attenuate the neurogenerative disorders by increasing neural plasticity and proliferation/differentiation of neural progenitor cells in dentate gyrus of hippocampus of normal adult mice and global ischemia model in gerbils. In addition, Yang et al. [
40] reported the cardioprotective effects of Rb1 through protection of cardiomyocytes from oxygen-glucose deprivation injuries by targeting microRNA-21 and its target gene programmed cell death protein 4 (PDCD4) in oxygen-glucose deprivation (OGD)-injured cardiomyocytes. Several recent studies have also reported the antidiabetic, anti-obesity and anti-aging effects as well as osteogenesis and angiogenesis effects to alleviate bone disorders. For instance, Zhou et al. [
41] have shown that Rb1 could exert protective effect on diabetes by regulating mitochondrial energy metabolism, improving insulin resistance and alleviating the diabetic complications, while Guo et al. [
42] demonstrated its anti-obesity activity through the reduction in body weight and improvement in glycolipid metabolism by upregulating proliferator activated receptor gamma (PPARγ) and aquaporin 7 (AQP7) protein levels. More recently, Wu et al. [
43] showed that Rb1 could reinforce the osteogenesis differentiation and angiogenesis factor’s expression of bone mesenchymal stem cells.